Icosavax Stock Net Income
| ICVXDelisted Stock | USD 9.02 0.12 1.31% |
Icosavax fundamentals help investors to digest information that contributes to Icosavax's financial success or failures. It also enables traders to predict the movement of Icosavax Stock. The fundamental analysis module provides a way to measure Icosavax's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Icosavax stock.
Icosavax |
Icosavax Company Net Income Analysis
Icosavax's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Icosavax Net Income | (96.71 M) |
Most of Icosavax's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Icosavax is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Icosavax reported net income of (96.71 Million). This is 128.34% lower than that of the Biotechnology sector and 238.07% lower than that of the Health Care industry. The net income for all United States stocks is 116.94% higher than that of the company.
Icosavax Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icosavax's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icosavax could also be used in its relative valuation, which is a method of valuing Icosavax by comparing valuation metrics of similar companies.Icosavax is currently under evaluation in net income category among its peers.
Icosavax Fundamentals
| Return On Equity | -0.42 | |||
| Return On Asset | -0.27 | |||
| Current Valuation | 547.9 M | |||
| Shares Outstanding | 50.23 M | |||
| Shares Owned By Insiders | 3.47 % | |||
| Shares Owned By Institutions | 87.64 % | |||
| Number Of Shares Shorted | 321.31 K | |||
| Price To Earning | 63.56 X | |||
| Price To Book | 3.31 X | |||
| Price To Sales | 153.31 X | |||
| Gross Profit | (30.97 M) | |||
| EBITDA | (103.19 M) | |||
| Net Income | (96.71 M) | |||
| Cash And Equivalents | 242.8 M | |||
| Cash Per Share | 6.09 X | |||
| Total Debt | 8.79 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 20.89 X | |||
| Book Value Per Share | 4.64 X | |||
| Cash Flow From Operations | (71.48 M) | |||
| Short Ratio | 0.34 X | |||
| Earnings Per Share | (2.20) X | |||
| Target Price | 18.5 | |||
| Number Of Employees | 60 | |||
| Beta | 1.28 | |||
| Market Capitalization | 769.04 M | |||
| Total Asset | 238.68 M | |||
| Retained Earnings | (185.83 M) | |||
| Working Capital | 210.12 M | |||
| Z Score | 51.0 | |||
| Net Asset | 238.68 M |
About Icosavax Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Icosavax's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icosavax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icosavax based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Icosavax Stock
If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |